ProfileGDS4132 / 202225_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 88% 89% 87% 84% 91% 89% 86% 93% 88% 89% 91% 92% 90% 90% 93% 90% 92% 87% 88% 92% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101366.23388
GSM201543Muscle PCOS pioglitazone 121370.99489
GSM201544Muscle PCOS pioglitazone 161380.37587
GSM201545Muscle PCOS pioglitazone 201338.11284
GSM201829Muscle PCOS pioglitazone 231479.79391
GSM201830Muscle PCOS pioglitazon 251387.78789
GSM201831Muscle PCOS pioglitazone 271359.39686
GSM201832Muscle PCOS pioglitazone 31587.76693
GSM201833Muscle PCOS pioglitazone 41373.83188
GSM201834Muscle PCOS pioglitazone 81431.95489
GSM201835Muscle PCOS after pioglitazone 102488.92591
GSM201836Muscle PCOS after pioglitazone 122518.57892
GSM201837Muscle PCOS after pioglitazone 162447.94690
GSM201838Muscle PCOS after pioglitazone 202496.07390
GSM201839Muscle PCOS after pioglitazone 232559.68493
GSM201840Muscle PCOS after pioglitazone 252478.03490
GSM201841Muscle PCOS after pioglitazone 272507.73692
GSM201842Muscle PCOS after pioglitazone 32354.95887
GSM201843Muscle PCOS after pioglitazone 42396.26188
GSM201844Muscle PCOS after pioglitazone 82570.02592